A small 30-patient, one-year confirmatory clinical trial in Japanese patients that compares NeoCart to microfracture

Trial Profile

A small 30-patient, one-year confirmatory clinical trial in Japanese patients that compares NeoCart to microfracture

Planning
Phase of Trial: Phase III

Latest Information Update: 17 Aug 2017

At a glance

  • Drugs Autologous chondrocyte implantation (Primary)
  • Indications Cartilage disorders; Knee injuries
  • Focus Registrational; Therapeutic Use
  • Sponsors Histogenics Corporation
  • Most Recent Events

    • 17 Aug 2017 New trial record
    • 10 Aug 2017 According to a Histogenics Corporation media release, the data from this trial and the one-year US phase 3 clinical trial data for NeoCart (see CT profile 243464) would be appropriate for submission to and potential approval by the Japan Pharmaceuticals and Medical Devices Agency (PMDA).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top